OCULAR THERAPEUTIX INC's ticker is OCUL and the CUSIP is 67576A100. A total of 114 filers reported holding OCULAR THERAPEUTIX INC in Q3 2023. The put-call ratio across all filers is 0.46 and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $50,262 | -93.3% | 16,007 | -85.0% | 0.00% | -100.0% |
| Q4 2021 | $746,000 | -75.2% | 106,970 | -85.9% | 0.00% | -80.0% |
| Q4 2019 | $3,004,000 | -48.3% | 760,490 | -60.2% | 0.01% | -54.5% |
| Q3 2019 | $5,805,000 | -38.9% | 1,909,478 | -11.5% | 0.02% | -35.3% |
| Q2 2019 | $9,496,000 | +38.8% | 2,158,149 | +25.2% | 0.03% | +30.8% |
| Q1 2019 | $6,842,000 | +44.8% | 1,723,456 | +45.1% | 0.03% | +23.8% |
| Q4 2018 | $4,726,000 | +36.6% | 1,187,508 | +136.0% | 0.02% | +61.5% |
| Q3 2018 | $3,461,000 | – | 503,117 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SUMMER ROAD LLC | 6,122,089 | $32,263 | 100.00% |
| Opaleye Management Inc. | 6,105,900 | $32,178,093 | 9.64% |
| DELTEC ASSET MANAGEMENT LLC | 1,913,612 | $10,084,735 | 2.49% |
| Knoll Capital Management, LLC | 200,000 | $1,504,000 | 2.32% |
| Endurant Capital Management LP | 512,744 | $2,702,161 | 1.39% |
| Knoll Capital Management, LLC | 95,800 | $504,866 | 0.78% |
| Covestor Ltd | 60,008 | $316 | 0.28% |
| Ikarian Capital, LLC | 200,000 | $1,054,000 | 0.24% |
| EAM Investors, LLC | 224,211 | $1,181,592 | 0.23% |
| Nebula Research & Development LLC | 22,474 | $118,438 | 0.21% |